Influenza A vaccine intranasal (Altimmune)

N/A

Report date: 2023/06/15 20:00:37

Base Information

Drug NameInfluenza A vaccine intranasal (Altimmune)
Drug Alias NameInfluenza A vaccine H5N1NasoVAXADhVN1203/04.H5
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAltimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltimmune Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus InfectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A